Does Childhood Treatment of ADHD With Stimulant Medication Affect Substance Abuse in Adulthood?
Open accessAbstract
One of the most controversial issues in childhood psychiatry is whether the wide-spread use of stimulant medications to treat children with attention deficit hyperactivity disorder (ADHD) increases the risk of substance abuse in adulthood.Part of the rationale for this concern is that stimulant medications (methylphenidate and amphetamine) share with drugs of abuse the ability to increase dopamine concentration in the nucleus accumbens, which is the neural mechanism considered crucial for their reinforcing effects (1).Indeed, methylphenidate and amphetamine are sometimes abused in some settings (2).This misuse can produce dependence.Another reason for concern is the timing of exposure.Human epidemiological studies have shown that the earlier an individual is exposed to substances with abuse potential, such as alcohol and nicotine, the greater the risk of drug abuse and dependence in adulthood (3).However, the opposite perspective has also been proposed-that stimulant treatment of children and adolescents with ADHD may reduce the risk of later substance abuse (4).Considering that individuals with ADHD are at higher-than-normal risk for substance abuse (5), it is urgent that these two perspectives be addressed properly, yet relatively few clinical studies have done so.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grant, B. F., & Dawson, D. A. (1997) · Journal of Substance Abuse · doi:10.1016/s0899-3289(97)90009-2 · Cited by 1,793 · see citing works
Wise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881 · see citing works
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872 · see citing works
The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics
Sonuga-Barke, E. J. S. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.005 · Cited by 816 · see citing works
Kessler, R. C., Adler, L. A., Barkley, R., Biederman, J., Conners, C. K., Faraone, S. V., Greenhill, L. L., Jaeger, S., Secnik, K., Spencer, T., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.001 · Cited by 663 · see citing works
Elkins, I. J., McGue, M., & Iacono, W. G. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1145 · Cited by 480 · see citing works
Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD
Volkow, N. D., & Swanson, J. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1909 · Cited by 475 · see citing works
Self-citationCostello, E. J., Foley, D. L., & Angold, A. C. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000184929.41423.c0 · Cited by 436 · see citing works
Volkow, N. D., Wang, G.-J., Newcorn, J., Telang, F., Solanto, M. V., Fowler, J. S., Logan, J., Ma, Y., Schulz, K., Pradhan, K., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.932 · Cited by 331 · see citing works
Self-citationMannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07091465 · Cited by 263 · cited 2× · see citing works
“(7), evaluates the age when stimulant treatment was initiated in childhood and its relationship to drug abuse in adulthood.”
BackgroundMOLINA, B. S. G., FLORY, K., HINSHAW, S. P., GREINER, A. R., ARNOLD, L. E., SWANSON, J. M., HECHTMAN, L., JENSEN, P. S., VITIELLO, B., HOZA, B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180686d96 · Cited by 255 · see citing works
Self-citationBiederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091486 · Cited by 239 · see citing works
What are the long-term effects of methylphenidate treatment?
Volkow, N. D., & Insel, T. R. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.019 · Cited by 111 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [10]Pelham WE. ADHD treatment with stimulant medication and later substance use; Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry; Washington, DC, AACAP. 2004. [Google Scholar]
Cited by
Sorted by citations
Sensitive periods of substance abuse: Early risk for the transition to dependence
Jordan, C. J., & Andersen, S. L. (2017) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2016.10.004 · Cited by 455 · see citing works
Molina, B. S. G., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E., Hechtman, L., Hoza, B., Epstein, J. N., Wigal, T., Abikoff, H. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.014 · Cited by 246 · see citing works
Self-citationStimulant Medication and Substance Use Outcomes
Humphreys, K. L., Eng, T., & Lee, S. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1273 · Cited by 211 · see citing works
Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at Pharmacotherapy
Ciccarone, D. (2011) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2010.11.004 · Cited by 200 · see citing works
Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis
Mészáros, Á., Czobor, P., Bálint, S., Komlósi, S., Simon, V., & Bitter, I. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990198 · Cited by 138 · see citing works
Substance Use in College Students With ADHD
Rooney, M. E., Chronis-Tuscano, A. M., & Yoon, Y. (2011) · Journal of Attention Disorders · doi:10.1177/1087054710392536 · Cited by 118 · see citing works
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
Wilens, T. E., Morrison, N. R., & Prince, J. B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.137 · Cited by 113 · see citing works
McCabe, S. E., Dickinson, K., West, B. T., & Wilens, T. E. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.03.011 · Cited by 82 · see citing works
Viggiano, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.033 · Cited by 82 · see citing works
Buitelaar, J. K., & Medori, R. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0056-1 · Cited by 80 · see citing works
The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining
Gonon, F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.010 · Cited by 79 · see citing works
Impulsivity and Vulnerability to Psychopathology
Neuhaus, E., & Beauchaine, T. P. (2017) · Wiley eBooks · doi:10.1002/9781394258932.ch6 · Cited by 63 · see citing works
Barkley, R. A. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1907 · Cited by 71 · see citing works
Graziano, P. A., Bagner, D. M., Waxmonsky, J. G., Reid, A. M., McNamara, J. P. H., & Geffken, G. R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.245 · Cited by 44 · see citing works
Ferrín, M., Ruíz-Veguilla, M., Blanc-Betes, M., El, S., Lax-Pericall, T., Sinclair, M., & Taylor, E. A. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0277-6 · Cited by 38 · see citing works
Jones, Z., & Dafny, N. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1101-2 · Cited by 37 · see citing works
Hammerness, P. G., Petty, C. R., Faraone, S. V., & Biederman, J. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712468051 · Cited by 36 · see citing works
Köck, P., Meyer, M., Elsner, J., Dürsteler, K. M., Vogel, M., & Walter, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.827658 · Cited by 37 · see citing works
Body Weight and ADHD: Examining the Role of Self-Regulation
Choudhry, Z., Sengupta, S. M., Grizenko, N., Harvey, W. J., Fortier, M., Schmitz, N., & Joober, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055351 · Cited by 36 · see citing works
O'Daly, O., Joyce, D., Stephan, K., Murray, R., & Shergill, S. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.3 · Cited by 27 · see citing works
Prescription Stimulant Medical and Nonmedical Use Among US Secondary School Students, 2005 to 2020
McCabe, S. E., Schulenberg, J. E., Wilens, T. E., Schepis, T. S., McCabe, V. V., & Veliz, P. T. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.8707 · Cited by 28 · see citing works
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Szobot, C. M., & Bukstein, O. G. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.003 · Cited by 26 · see citing works
Age and Cohort Patterns of Medical and Nonmedical Use of Controlled Medication Among Adolescents
Austic, E. A., McCabe, S. E., Stoddard, S. A., Ngo, Q. E., & Boyd, C. J. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000142 · Cited by 25 · see citing works
Long-Term Safety of Stimulant Use for ADHD: Findings from Nonhuman Primates
Volkow, N. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.127 · Cited by 24 · see citing works
Self-citationMcCabe, S. E., Schulenberg, J. E., Wilens, T. E., Schepis, T. S., McCabe, V. V., & Veliz, P. T. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.22650 · Cited by 22 · see citing works
Jordan, C. J., Taylor, D. M., Dwoskin, L. P., & Kantak, K. M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.017 · Cited by 22 · see citing works
McCabe, S. E., Figueroa, O., McCabe, V. V., Schepis, T. S., Schulenberg, J. E., Veliz, P. T., Werner, K. S., & Wilens, T. E. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13807 · Cited by 22 · see citing works
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Bukstein, O. G. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_148 · Cited by 19 · see citing works
McCabe, S. E., Veliz, P. T., & Boyd, C. J. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.019 · Cited by 16 · see citing works
Cardullo, S., Pérez, L. J. G., Cuppone, D., Sarlo, M., Cellini, N., Terraneo, A., Gallimberti, L., & Madeo, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.659527 · Cited by 16 · see citing works
Lange, K. W. (2017) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/mnhd.4 · Cited by 15 · see citing works
Gill, K. E., Chappell, A. M., Beveridge, T. J. R., Porrino, L. J., & Weiner, J. L. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12489 · Cited by 12 · see citing works
Eme, R. F. (2012) · ISRN Addiction · doi:10.1155/2013/815096 · Cited by 12 · see citing works
Genome-wide association study of stimulant dependence
Cox, J. W., Sherva, R., Wetherill, L. F., Foroud, T., Edenberg, H. J., Kranzler, H. R., Gelernter, J. E., & Farrer, L. A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01440-5 · Cited by 12 · see citing works
Pereira, M. D. S., Sathler, M. F., Valli, T. D. R., Marques, R. S., Ventura, A., Peccinalli, N. R., Fraga, M., Manhães, A. C., & Kubrusly, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141249 · Cited by 10 · see citing works
The Ethics of Neuroenhancement
Wagner, N., Robinson, J., & Wiebking, C. (2015) · International Journal of Technoethics · doi:10.4018/ijt.2015010101 · Cited by 10 · see citing works
Wigal, S. B., Raja, P., & Shukla, A. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.754013 · Cited by 9 · see citing works
Guarraci, F. A., Holifield, C., Morales-Valenzuela, J., Greene, K., Brown, J., Lopez, R., Crandall, C., Gibbs, N., Vela, R., Delgado, M. Y., et al. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.12.003 · Cited by 8 · see citing works
Slade, E., Dwoskin, L. P., Zhang, G., Talbert, J., Chen, J., Freeman, P. R., Kantak, K. M., Hankosky, E. R., Fouladvand, S., Meadows, A. L., et al. (2020) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.521 · Cited by 7 · see citing works
McCabe, V. V., Veliz, P. T., Wilens, T. E., Schepis, T. S., Pasman, E., Evans‐Polce, R. J., & McCabe, S. E. (2024) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2024.01.024 · Cited by 6 · see citing works
The Societal Hazards of Neuroenhancement Technologies
Wagner, N., Robinson, J., & Wiebking, C. (2018) · Advances in information security, privacy, and ethics book series · doi:10.4018/978-1-5225-5094-5.ch010 · Cited by 5 · see citing works
Peña, I. D., Ahn, H. S., Ryu, J. H., Shin, C. Y., Park, I.-H., & Cheong, J. H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.057 · Cited by 5 · see citing works
Medina, A. C., Kabani, A. A., Reyes-Vasquez, C., & Dafny, N. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02526-0 · Cited by 5 · see citing works
Attention-Deficit Hyperactivity Disorder
Swanson, J. M., Rommelse, N. N. J., Cotton, J., Sonuga-Barke, E. J. S., Jensen, P. S., & Castellanos, F. X. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_169-2 · Cited by 4 · see citing works
Self-citationAttention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death
Besag, F. (2009) · Drug Safety · doi:10.2165/11530340-000000000-00000 · Cited by 4 · see citing works
Behavioral, Cognitive, and Affective Consequences of Trying to Avoid Chocolate
Erskine, J., & Georgiou, G. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-803-0_36 · Cited by 4 · see citing works
Kurt, Z. K., Hacıosmanoğlu, G. D., Yıldırım, M., & Özaslan, A. (2024) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2023.2299873 · Cited by 3 · see citing works
Le trouble déficit de l’attention-hyperactivité et ses relations avec les conduites addictives
Delavenne, H., & Thibaut, F. (2009) · PSN · doi:10.1007/s11836-009-0090-6 · Cited by 3 · see citing works
Psychopharmacology of Pediatric Attention-Deficit/Hyperactivity Disorder
Greydanus, D. E., Rowland, D. C., Patel, D. R., & Soares, N. S. (2021) · Psychiatric Annals · doi:10.3928/00485713-20210914-01 · Cited by 2 · see citing works
Methylphenidate Conditioned Place Preference in Juvenile and Adolescent Male and Female Rats
Freeman, E. D. (2013) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 2 · see citing works
Attention-Deficit Hyperactivity Disorder
Swanson, J. M., Rommelse, N. N. J., Cotton, J., Sonuga-Barke, E. J. S., Jensen, P. S., & Castellanos, F. X. (2022) · Springer eBooks · doi:10.1007/978-3-030-88832-9_169 · Cited by 2 · see citing works
Self-citationWEINBERG, N. Z., Lopez, M. F., & Compton, W. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00003-4 · Cited by 2 · see citing works
Dafny, N., Claussen, C. M., Frazier, E., & Liu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115938 · Cited by 1 · see citing works
Brain Development and the Risk for Substance Use, Misuse, and Substance Use Disorders
Ruiz, S. G., Casey, B. J., & Baskin-sommers, A. R. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0049 · Cited by 1 · see citing works
Pasman, E., Veliz, P. T., Patrick, M. E., Schepis, T. S., McCabe, V. V., Wilens, T. E., & McCabe, S. E. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112760 · Cited by 1 · see citing works
ADHD Co-Occurring Conditions: A Multidisciplinary Approach
Das, J., & Biswal, J. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011823 · Cited by 1 · see citing works
Das ADHS Kaleidoskop: State of the Art und bisher nicht beachtete Aspekte von hoher Relevanz
Universität Rostock, D., & Häßler, F. (2008) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954661886 · Cited by 1 · see citing works
Brain Development and the Risk for Substance Abuse
Heitzeg, M. M., & Casey, B. J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0047 · Cited by 1 · see citing works
McCabe, S. E., Schepis, T. S., Schulenberg, J. E., Wilens, T. E., & Veliz, P. T. (2024) · Substance Use & Addiction Journal · doi:10.1177/29767342231219139 · Cited by 1 · see citing works
Wolf, M. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00061-4 · Cited by 1 · see citing works
Катан, Е. А. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2020120111141 · Cited by 2 · see citing works
Sihvola, E. (2010) · Työväentutkimus Vuosikirja · Cited by 1 · see citing works
AD/HD and adolescent substance use: the impact of subtype, parenting practices, and conduct problems
Benson, J. W. (2010) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Jones, Z. (2013) · Digital Commons-TMC (Texas Medical Center)
Malow, R. M., Rosenberg, R., & Dévieux, J. G. (2011) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109711430924
Bukstein, O. G. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0003-6
Patte, K. A. (2015) · YorkSpace (York University)
Gill, K. E. (2013) · WakeSpace Scholarship (Wake Forest University)
Bandel, T. (2013) · Psihološka obzorja · doi:10.20419/2012.21.369
Thelen, H. (2016) · psychopraxis neuropraxis · doi:10.1007/s00739-016-0322-1
Schmidt, H.-R. (2019) · Springer eBooks · doi:10.1007/978-3-658-14130-1_18
Häßler, F. (2008) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954661886-7
Thelen, H. (2016) · Pädiatrie & Pädologie · doi:10.1007/s00608-015-0334-8
(2010) · Wiley eBooks · doi:10.1002/9781444328172.refs
The Ethics of Neuroenhancement
Wagner, N., Robinson, J., & Wiebking, C. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-7666-2.ch005
Focused Neuroregulation in the Treatment and Prevention of Mental and Physical Illness
Binder, M. R. (2022) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20221002.11
Weir, P. A., Tevis, C. M., & Matson, J. L. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-24926-6_25
(2025) · Wiley eBooks · doi:10.1002/9781118941430.refs
Calandro, A. D., Biswas, S., & Guiseppi‐Elie, A. (2025) · JMIR Neurotechnology · doi:10.2196/68736
Common Treatments of Attention/Deficit Hyperactivity Disorder
Nilsson, K. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Tarter, R. E., & Horner, M. S. (2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370221.lg01
Alyahya, K., Alshabani, S. M., Alageel, L. A., Alasmari, R. S., Shaheen, T. E., Alkanhal, A., & Albabtain, A. (2026) · Cureus · doi:10.7759/cureus.115587
- Authors
- Volkow, N. D., & Swanson, J. M.
- Venue
- American Journal of Psychiatry
- Published
- 2008-05
- Volume
- 165
- Issue
- 5
- Pages
- 553-555
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC2667111
- OpenAlex
- W2106676766
- Cited by
- 85
- References
- 13
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 3 · 2013: 8 · 2012: 8
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 DA999999)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, methylphenidate, amphetamine, substance abuse, substance dependence, dopamine, nucleus accumbens, reinforcement
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Follow-Up Studies, Humans, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
